Managing non-24-hour sleep-wake rhythm disorder with ramelteon in a 12-year-old girl with Pierre Robin sequence and developmental delay: a case report.
J Clin Sleep Med
; 20(6): 995-997, 2024 Jun 01.
Article
en En
| MEDLINE
| ID: mdl-38305773
ABSTRACT
The author recently observed a case involving a 12-year-old sighted girl who exhibited symptoms typical of non-24-hour sleep-wake rhythm disorder (N24SWD). This disorder, more commonly found in blind individuals, presents a unique challenge when diagnosed in those with vision. Several interventions can be attempted, ranging from behavioral adjustments to light therapy. Although melatonin has been noted for its effectiveness in realigning the patient's sleep-wake cycle, the use of ramelteon, a melatonin receptor agonist, has seldom been reported in managing N24SWD. However, this case illuminates the potential of ramelteon as another therapeutic option for sighted individuals with N24SWD. Further study is suggested to determine the potential of ramelteon in managing this disorder among sighted individuals of varying age groups. CITATION Huang C-H. Managing non-24-hour sleep-wake rhythm disorder with ramelteon in a 12-year-old girl with Pierre Robin sequence and developmental delay a case report. J Clin Sleep Med. 2024;20(6)995-997.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Síndrome de Pierre Robin
/
Discapacidades del Desarrollo
/
Trastornos del Sueño del Ritmo Circadiano
/
Indenos
Idioma:
En
Revista:
J Clin Sleep Med
Año:
2024
Tipo del documento:
Article
País de afiliación:
Taiwán